首页> 美国卫生研究院文献>BMC Biotechnology >A comparison between quantitative PCR and droplet digital PCR technologies for circulating microRNA quantification in human lung cancer
【2h】

A comparison between quantitative PCR and droplet digital PCR technologies for circulating microRNA quantification in human lung cancer

机译:定量PCR和液滴数字PCR技术在肺癌中循环microRNA定量的比较。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundSelected microRNAs (miRNAs) that are abnormally expressed in the serum of patients with lung cancer have recently been proposed as biomarkers of this disease. The measurement of circulating miRNAs, however, requires a highly reliable quantification method. Quantitative real-time PCR (qPCR) is the most commonly used method, but it lacks reliable endogenous reference miRNAs for normalization of results in biofluids. When used in absolute quantification, it must rely on the use of external calibrators. Droplet digital PCR (ddPCR) is a recently introduced technology that overcomes the normalization issue and may facilitate miRNA measurement. Here we compared the performance of absolute qPCR and ddPCR techniques for quantifying selected miRNAs in the serum.
机译:背景技术最近提出了在肺癌患者的血清中异常表达的选择的微小RNA(miRNA)作为该疾病的生物标记。但是,循环miRNA的测量需要高度可靠的定量方法。实时定量PCR(qPCR)是最常用的方法,但它缺乏可靠的内源参考miRNA来标准化生物流体中的结果。当用于绝对定量时,它必须依靠外部校准器的使用。液滴数字PCR(ddPCR)是最近推出的一项技术,它克服了标准化问题,并可能有助于miRNA测量。在这里,我们比较了绝对定量PCR和ddPCR技术对定量选择的血清中miRNA的性能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号